This product aims to enhance early cervical cancer detection for women. Many avoid screenings due to cost, distance, or accessibility. The solution offers simple self-sampling, allowing women to privately and safely take the first step without an immediate hospital visit. Samples are tested using PCR-based HPV DNA detection for reliable results.

PCR-based HPV DNA detection (“highly sensitive PCR-based detection”)
>95% accuracy

"Independently verified by the Karolinska Institute (Sweden)"

-HPV 16/18/45
-IFU CarciScan: detects multiple high-risk
HPV types including HPV16, HPV18, HPV31,
HPV33, HPV45, and HPV52.

Home use is explicitly intended (self-sampling kits can also be used clinically)

Production capacity: up to 1,000,000 kits per month

"Price barrier is drastically reduced."

Results 24–48 hours after sample arrives at the lab

Already in use in Ghana and Turkey